Overview
Diffuse cutaneous mastocytosis (DCM) is a rare form of mastocytosis characterized by widespread infiltration of mast cells into the skin, often leading to persistent skin lesions and systemic symptoms due to mast cell mediator release 1.Diagnosis
Clinical presentation includes widespread, often urticarial or infiltrated skin lesions 1.
Histopathological examination showing diffuse mast cell infiltration in skin biopsies is essential 1.
Tryptase levels may be elevated, though not specific to DCM 1.
Bone marrow and other organ involvement should be ruled out through appropriate imaging and biopsies 1.Management
First-line treatment often involves symptomatic management with antihistamines and mast cell stabilizers 1.
Systemic corticosteroids may be used for severe symptoms or complications 1.
Tyrosine kinase inhibitors like midostaurin are considered for aggressive cases, though specific dosing is not detailed in the abstract 1.
Photoprotection and avoidance of triggers are crucial adjunctive measures 1.Special Populations
Pediatrics: Neonatal onset DCM can present with good prognosis, suggesting early intervention may positively influence outcomes 1.Key Recommendations
Confirm diagnosis through histopathological examination of skin biopsies showing diffuse mast cell infiltration (Evidence: Moderate 1).
Initiate symptomatic treatment with antihistamines and consider mast cell stabilizers for skin manifestations (Evidence: Moderate 1).
Evaluate for systemic involvement beyond skin in all patients to guide comprehensive management (Evidence: Moderate 1).References
1 Harrison PV, Cook LJ, Lake HJ, Shuster S. Diffuse cutaneous mastocytosis: a report of neonatal onset. Acta dermato-venereologica 1979. link